Federal Circuit Upholds Board In Dispute Over Multiple Sclerosis Treatment
WASHINGTON, D.C. — In an Oct. 24 ruling, the Federal Circuit U.S. Court of Appeals agreed with the Patent Trial and Appeal Board that a patent application covering the controlled release...To view the full article, register now.
Already a subscriber? Click here to view full article